"⚡💙Progress.

In Feb the #FDA🚨refused to even begin reviewing the first mRNA flu vaccine.

This week, the Vaccines Advisory Committee⚡voted unanimously that the benefits outweigh the risks for adults 50 and older - because the data supported it.

The way science should be done."
-Dr C Young

#Vaccines #Flu #mRNA #HHS #Health #PublicHealth #FDA #Science #USPol
https://www.pbs.org/newshour/health/fda-panel-backs-first-of-its-kind-flu-vaccine-using-mrna-technology

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.

PBS News